周围动脉疾病管理:来自SerbVasc注册表的见解
Slobodan Tanaskovic1,2, Nenad Ilijevski1,2, Lazar Davidovic2,3
1Vascular Surgery Clinic, Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia.
塞尔维亚的周围动脉疾病 (PAD) 治疗表明男性接受更多的开放手术. 糖尿病和吸烟会影响结果,而通过轻微截肢的重血管化可以减少重大截肢.
科学领域:
- 血管外科 血管外科
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 周围动脉疾病 (PAD) 的管理在全球范围内有所不同,需要特定区域的数据.
- 在VASCUNET (血管网络) 的合作收集有关血管程序的数据.
- 了解塞尔维亚的PAD治疗方法为类似的医疗保健系统提供了洞察力.
研究的目的:
- 在VASCUNET合作中分析来自塞尔维亚的外周动脉疾病 (PAD) 治疗数据.
- 为了研究性别差异,再血管化方法和PAD管理中的患者结果.
- 确定PAD患者患病率和死亡率的风险因素和预测因素.
主要方法:
- 从塞尔维亚27家医院 (SerbVasc注册) 的1681名PAD患者的数据分析.
- 专注于性别差异,糖尿病患病率,吸烟史和以前的干预措施.
- 评估并发症率,住院死亡率和截肢结果.
主要成果:
- 男性占患者的69.5%,更有可能接受开放式手术治疗.
- 糖尿病 (40.2%) 和吸烟 (61.9%) 是普遍存在的,显著影响疾病进展和并发症.
- 住院死亡率为1.6%,由紧急手术和最近的心肌梗塞预测;通过轻微截肢的再血管化降低了主要截肢率.
结论:
- 塞尔维亚Vasc数据提供了塞尔维亚PAD管理的全面视图,突出了糖尿病和吸烟的重大影响.
- 研究结果强调需要解决性别差异,优化治疗策略,包括截肢的综合方法.
- 该研究提供了有价值的数据,以改善塞尔维亚和同类医疗机构的PAD患者的治疗结果.
更多相关视频
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
14:52Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
相关概念视频
Rheumatic Heart Disease III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Rheumatic Heart Disease IV: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
